Search
for
Sort by
Research 31–60 of 1000+
- Attending persistent T cell activation in alopecia areata : A therapeutic option
- Alopecia areata: current concepts
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- APECED: JAK Inhibition in an Adult Case with Long-Term Follow-up
- Alopecia Areata Associated with Dupilumab: A Case Report and Literature Review
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Rare and Underappreciated Causes of Polycystic Ovarian Syndrome
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Alopecia areata – Aktuelles Verständnis und Management
- Alopecia Areata: Imunopatogênese e Terapias Emergentes
- Alopecia Areata: Estudio de las Nuevas Perspectivas de Tratamiento y de su Impacto en la Calidad de Vida y Salud Sexual
- Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Multi-omics analyses, cell experiments, and network pharmacology tools identified key proteins and candidate drugs for alopecia areata treatment
- The pharmacological treatment of alopecia areata
- Symposium Proceedings of the 4th Intercontinental Meeting of Hair Research Societies: “The World of Hair 2004”
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Controlled Delivery of T-box21 Small Interfering RNA Ameliorates Autoimmune Alopecia (Alopecia Areata) in a C3H/HeJ Mouse Model
- Exosomes: Cutting-Edge Therapies for Autoimmune Dermatologic Diseases
- The autoimmune basis of alopecia areata: A comprehensive review
- <i>In vivo </i>CD44‐CD49d complex formation in autoimmune disease has consequences on T cell activation and apoptosis resistance
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Vitiligo and alopecia areata: apples and oranges?
- Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation